VIRTUAL TOXICITY AND DRUG LIKENESS OF NEWLY SYNTHESIZED METHYLXANTHINES WITH N1 ARYLPIPERAZINE MOIETY
AbstractAiming to obtain preliminary information on the toxicity, stability and pharmacokinetic behavior of a group of 12 methylxanthines, containing an arylpiperazine moiety at N1, we applied three virtual methods for prediction. The online hazard-screening tool-PBT profiler was used for toxicity evaluation. The pharmacokinetic behavior and drug like properties of the tested compounds were predicted by two online platforms: Molinspiration Cheminformatics and OSIRIS web-based server. The PBT-profiler tool determined, that the investigated compounds are soil persistent, do not bioaccumulate in the food chain and with the exception of the structures containing bulky bi-phenyl substituents all other molecules are of moderate toxicity. All tested compounds meet Lipinski’s Rule of Five border conditions and have high values for drug likeness and drug score, which makes them suitable for future optimizations.
Andonova, L., Zheleva-Dimitrova, D., Georgieva, M., Zlatkov, Al. (2014). Synthesis and antioxidant activity of some 1-aryl/aralkyl piperazine derivatives with xanthine moiety at N4. Biotechnol Biotechnol Equip, 28(6), 1165–1171.
Boike, G.M., Petru, E., Sevin, B.U., Averette, H.E., Chou, T.C., Penalver, M., Donato, D., Schiano, M., Hilsenbeck, S.G., Perras, J. (1990). Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell line. Gynecologic Оncology, 38(3), 315-22.
Cassani, S., Gramatica, P. (2015). Identification of potential PBT behavior of personal care products by structural approaches. Sustainable Chemistry and Pharmacy, 1, 19-27
Georgieva, M., Mitkov, J., Zlatkov, Al. (2014). Synthesis and druglikeness estimation of amide derivatives of 1-benzyltheobromine8-thioglycolic acid. Scripta Scientifica Pharmaceutica, 1, 28-37.
Ghannay, S., Bakari, S., Ghabi, A., Kadri, A., Msaddek, M., Aouadi, K. (2017). Stereoselective synthesis of enantiopure N-substituted pyrrolidin-2,5-dione derivatives by 1,3-dipolar cycloaddition and assessment of their in vitro antioxidant and antibacterial activities. Bioorganic & Medicinal Chemistry Letters, 27(11), 2302-2307.
Husain, A., Rosales, N., Schwartz, G.K., Spriggs, D.R. (1998). Lisofylline Sensitizes p53 Mutant Human Ovarian Carcinoma Cells to the Cytotoxic Effects of cis-diamminedichloroplatinum (II). Gynecologic Oncology, 70(1), 17-22.
Leeson, P.D., Springthorpe, B. (2007). The influence of druglike concepts on decision-making in medicinal chemistry. Nat Rev Drug Discov, 6(11), 881-90.
Lipinski, C.A. (2004). Lead- and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technologies, 1(4), 337-41.
Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev, 46(1-3), 3-26.
Molinspiration Cheminformatics, 2012, retrieved from www.molinspiration.com.
Nadeem, S., Sirajuddin, M., Ahmad, S., Tirmizi, S.A., Ali, M.I., Hameed, A. (2016). Synthesis, spectral characterization and in vitro antibacterial evaluation and Petra/Osiris/Molinspiration analyses of new Palladium(II) iodide complexes with thioamides. Alexandria Journal of Medicine, 52(3), 279-288.
Obniska, J., Pawłowski, M., Kołaczkowski, M., Czopek, A., Duszyńska, B., Kłodzińska, A., Tatarczyńska, E.,Chojnacka-Wójcik, E. (2003). Synthesis and 5-HT1A/5-HT2A receptor activity of new N-[3-(4-phenylpiperazin-1-yl)-propyl] derivatives of 3-spiro-cyclohexane pyrrolidine-2,5-dione and 3-spiro-β-tetralonepyrrolidine-2,5-dione. Pol. J. Pharmacol, 55, 553–557.
OSIRIS Property Explorer. http://www.organic-chemistry.org/prog/peo/
Pietrzycka, A., Stepniewski, M., Waszkielewicz, A.M., Marona, H. (2006). Preliminary evaluation of antioxidant activity of some 1-(phenoxyethyl)-piperazine derivatives. Acta Poloniae Pharmaceutica - Drug Research, 63(1), 19-24.
Rorije, E., Verbruggen, E.M.J., Hollander, A., Traas, T.P., Janssen, M.P.M. (2011). Identifying potential POP and PBT substances Development of a new Persistence/ Bioaccumulation score, Report 601356001/2011, National Institute for Public Health and the Environment, 18-24.
Sangion, A., Gramatica, P. (2016) PBT assessment and prioritization of contaminants of emerging concern. Pharmaceuticals, Environmental Research, 147, 297-306.
Smith, K.S., Folz, B.A., Adams, E.G., Bhuyan, B.K. (1995). Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin. Cancer Chemotherapy and Pharmacology, 35(6), 471-82.
Zhao, Y.H., Abraham, M.H., Lee, J., Hersey, A., Luscombe, C.N., Beck G. (2002). Rate-limited steps of human oral absorption and QSAR studies. Pharm Res, 19, 1446-57.
Zlatkov, A.B., Peikov, P.T., Momekov, G.C., Pencheva, I., Tsvetkova, B. (2010). Synthesis, stability and computational study of some ester derivatives of theophylline-7-acetic acid with antiproliferative activity. Der Pharma Chemica, 2(6), 197-210
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (Creative Commons Attribution License 3.0 - CC BY 3.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
firstname.lastname@example.org, www.iseic.cz, ojs.journals.cz